CAD 0.2
(14.29%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2022 | -2.34 Million CAD | -171.93% |
2021 | 3.25 Million CAD | 0.0% |
2019 | -358 Thousand CAD | -100.98% |
2018 | 36.57 Million CAD | 1155.37% |
2017 | -3.46 Million CAD | -172.6% |
2016 | 4.77 Million CAD | -78.14% |
2015 | 21.84 Million CAD | -18.91% |
2014 | 26.93 Million CAD | 721.35% |
2013 | 3.27 Million CAD | -77.93% |
2012 | 14.85 Million CAD | 192.02% |
2011 | -16.14 Million CAD | -261.12% |
2010 | 10.01 Million CAD | 139.16% |
2009 | 4.18 Million CAD | 206.43% |
2008 | -3.93 Million CAD | -6325.85% |
2007 | 63.23 Thousand CAD | 709.73% |
2006 | 7809.00 CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 Q2 | -15.95 Million CAD | -625.0% |
2023 Q1 | -2.2 Million CAD | 42.14% |
2023 Q3 | -8.32 Million CAD | 47.83% |
2022 Q3 | 1.88 Million CAD | 405.02% |
2022 Q4 | -3.8 Million CAD | -302.02% |
2022 FY | -2.34 Million CAD | -171.93% |
2022 Q1 | 217 Thousand CAD | -92.3% |
2022 Q2 | -617 Thousand CAD | -384.33% |
2021 FY | 3.25 Million CAD | 0.0% |
2021 Q2 | -628 Thousand CAD | -141.05% |
2021 Q4 | 2.82 Million CAD | 487.36% |
2021 Q3 | -728 Thousand CAD | -15.92% |
2021 Q1 | 1.53 Million CAD | 0.0% |
2020 Q2 | -2.65 Million CAD | -276.54% |
2020 Q3 | -326 Thousand CAD | 87.73% |
2020 Q1 | 1.5 Million CAD | 261.78% |
2019 Q2 | -1.12 Million CAD | -102.9% |
2019 Q4 | 416 Thousand CAD | 135.92% |
2019 FY | -358 Thousand CAD | -100.98% |
2019 Q1 | 38.59 Million CAD | 3099.83% |
2019 Q3 | -1.15 Million CAD | -3.3% |
2018 Q4 | 1.2 Million CAD | 171.83% |
2018 FY | 36.57 Million CAD | 1155.37% |
2018 Q3 | -1.67 Million CAD | -9.17% |
2018 Q1 | -564 Thousand CAD | -157.43% |
2018 Q2 | -1.53 Million CAD | -172.7% |
2017 Q1 | 276 Thousand CAD | -78.35% |
2017 Q3 | 1.26 Million CAD | 35.16% |
2017 Q4 | 982 Thousand CAD | -22.13% |
2017 Q2 | 933 Thousand CAD | 238.04% |
2017 FY | -3.46 Million CAD | -172.6% |
2016 Q2 | 1.66 Million CAD | -90.43% |
2016 Q4 | 1.27 Million CAD | -38.82% |
2016 Q1 | 17.35 Million CAD | 158.15% |
2016 Q3 | 2.08 Million CAD | 25.47% |
2016 FY | 4.77 Million CAD | -78.14% |
2015 Q2 | 5.43 Million CAD | 76.51% |
2015 Q3 | 5.77 Million CAD | 6.31% |
2015 Q4 | 6.72 Million CAD | 16.38% |
2015 FY | 21.84 Million CAD | -18.91% |
2015 Q1 | 3.07 Million CAD | 142.76% |
2014 Q1 | 399.45 Thousand CAD | 47.89% |
2014 Q4 | -7.19 Million CAD | -189.75% |
2014 Q3 | 8.02 Million CAD | -1.51% |
2014 Q2 | 8.14 Million CAD | 1938.8% |
2014 FY | 26.93 Million CAD | 721.35% |
2013 FY | 3.27 Million CAD | -77.93% |
2013 Q3 | 88.61 Thousand CAD | -96.72% |
2013 Q4 | 270.09 Thousand CAD | 204.79% |
2013 Q2 | 2.69 Million CAD | -66.41% |
2013 Q1 | 8.03 Million CAD | 1931.53% |
2012 Q3 | 4.16 Million CAD | 84.66% |
2012 Q4 | 395.38 Thousand CAD | -90.52% |
2012 FY | 14.85 Million CAD | 192.02% |
2012 Q2 | 2.25 Million CAD | 134.13% |
2012 Q1 | -6.61 Million CAD | -206.22% |
2011 Q1 | -5.05 Million CAD | -140.47% |
2011 Q4 | 6.22 Million CAD | 77.21% |
2011 Q2 | 3.17 Million CAD | 162.84% |
2011 Q3 | 3.51 Million CAD | 10.71% |
2011 FY | -16.14 Million CAD | -261.12% |
2010 FY | 10.01 Million CAD | 139.16% |
2010 Q3 | -2.09 Million CAD | -243.32% |
2010 Q2 | 1.45 Million CAD | -78.68% |
2010 Q1 | 6.84 Million CAD | 1151.82% |
2010 Q4 | -2.1 Million CAD | -0.48% |
2009 FY | 4.18 Million CAD | 206.43% |
2009 Q1 | -1.75 Million CAD | -266.9% |
2009 Q4 | -650.55 Thousand CAD | -19.26% |
2009 Q2 | -1.47 Million CAD | 15.8% |
2009 Q3 | -545.47 Thousand CAD | 63.09% |
2008 Q3 | 7907.00 CAD | 2.42% |
2008 Q1 | 18.41 Thousand CAD | 1024.74% |
2008 FY | -3.93 Million CAD | -6325.85% |
2008 Q4 | 1.05 Million CAD | 13201.73% |
2008 Q2 | 7720.00 CAD | -58.07% |
2007 Q3 | 31.09 Thousand CAD | 357.21% |
2007 Q4 | 1637.00 CAD | -94.74% |
2007 FY | 63.23 Thousand CAD | 709.73% |
2007 Q2 | -12.08 Thousand CAD | 0.0% |
2006 FY | 7809.00 CAD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
MustGrow Biologics Corp. | -210.93 Thousand CAD | -1009.373% |